<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00947219</url>
  </required_header>
  <id_info>
    <org_study_id>9.12 2009-M-02</org_study_id>
    <nct_id>NCT00947219</nct_id>
  </id_info>
  <brief_title>Treatment of Androgenic Alopecia in Males</brief_title>
  <official_title>A Randomized, Double-Blind, Control Device Clinical Trial to Evaluate the Safety and Efficacy of the HairMax LaserComb 2009, 9 &amp; 12 Beam Models: For the Treatment of Androgenetic Alopecia in Males</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lexington International, LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lexington International, LLC</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the change in terminal hair count at 16 and 26 weeks
      compared to baseline measurements.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is randomized, double-blind, control device clinical study across 3 sites, evaluating
      changes in terminal hair-count in the evaluation zone having evidence of androgenetic
      alopecia (miniaturized hair).

      The trial will involve approximately 75 male subjects who have been diagnosed with
      androgenetic alopecia, who are between 25 and 60 years of age, have Fitzpatrick Skin Types
      I-IV, with classifications of Norwood-Hamilton IIa to V, have active hair loss within the
      last 12 months.

      Subjects will use the device on three non-consecutive days a week as directed per device for
      26 weeks treatment duration.

      Safety analysis will be assessed based on the reports of adverse events during study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2009</start_date>
  <completion_date type="Actual">August 2010</completion_date>
  <primary_completion_date type="Actual">August 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in Terminal Hair Count at 16 and 26 Weeks Compared to Baseline in Men Diagnosed With Androgenetic Alopecia</measure>
    <time_frame>baseline, 16 and 26 weeks</time_frame>
    <description>The primary analysis of effectiveness was an analysis of covariance, which separately modeled terminal hair count at Week 16 and Week 26 as a function of treatment group (HairMax LaserComb 2009 9 Beam vs.control), study center, age (as a continuous variable), and Fitzpatrick Skin Type classification (as a categorical variable with four levels). The active group was compared to the control device using least squares means with a two-sided test at the 5% level of significance.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">79</enrollment>
  <condition>Androgenetic Alopecia</condition>
  <condition>Hair Loss</condition>
  <condition>Male Pattern Baldness</condition>
  <arm_group>
    <arm_group_label>HairMax LaserComb 2009, 12 Beam</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Low Level Laser Medical Device 2009 with 12 laser beams</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HairMax LaserComb 2009 9 Beam</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Low Level Laser Mecial Device 2009 with 9 laser beams</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control device</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The control device appears identical to the active device, but utilizes 9 LED lights instead of laser lights. The randomized devices are blinded to the study investigator and distributed in a blinded manner to the participants.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HairMax LaserComb</intervention_name>
    <description>Device application 3 times week (non-consecutive days), for 26 weeks</description>
    <arm_group_label>HairMax LaserComb 2009, 12 Beam</arm_group_label>
    <arm_group_label>HairMax LaserComb 2009 9 Beam</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Control device</intervention_name>
    <description>Device is used 3 times a week on non-consecutive days</description>
    <arm_group_label>Control device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of androgenetic alopecia

          -  Fitzpatrick Skin Types I-IV

          -  Norwood-Hamilton IIa to V

          -  Active hair loss within last 12 months

        Exclusion Criteria:

          -  Photosensitivity to laser light

          -  Malignancy in the target area
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zoe Draelos, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>High Point, NC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David Goldberg, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Skin &amp; Laser</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Abe Marcadis, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Palm Beach Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Abe Marcadis, M.D.</name>
      <address>
        <city>West Palm Beach</city>
        <state>Florida</state>
        <zip>33409</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>David Goldberg, M.D.</name>
      <address>
        <city>Hackensack</city>
        <state>New Jersey</state>
        <zip>07601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zoe Draelos, M.D.</name>
      <address>
        <city>High Point</city>
        <state>North Carolina</state>
        <zip>27262</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Leavitt M, Charles G, Heyman E, Michaels D. HairMax LaserComb laser phototherapy device in the treatment of male androgenetic alopecia: A randomized, double-blind, sham device-controlled, multicentre trial. Clin Drug Investig. 2009;29(5):283-92. doi: 10.2165/00044011-200929050-00001.</citation>
    <PMID>19366270</PMID>
  </reference>
  <verification_date>December 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 27, 2009</study_first_submitted>
  <study_first_submitted_qc>July 27, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 28, 2009</study_first_posted>
  <results_first_submitted>January 6, 2011</results_first_submitted>
  <results_first_submitted_qc>December 21, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 31, 2013</results_first_posted>
  <last_update_submitted>December 21, 2012</last_update_submitted>
  <last_update_submitted_qc>December 21, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 31, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Androgenetic Alopecia</keyword>
  <keyword>Hair Loss</keyword>
  <keyword>Male Pattern Baldness</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alopecia</mesh_term>
    <mesh_term>Alopecia Areata</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Male subjects who have been diagnosed with androgenetic alopicia, who are between 25 and 60 years of age, have Fitzpatrick Skin Types i-IV and Norwood Hamilton Classifications of IIa to IV and have active hair loss with the last 12 months</recruitment_details>
      <pre_assignment_details>Exclusion criteria: Individuals with photosensitivity to laser light, history of any malignancy in target area, has used phytotherapy (e.g. saw palmetto) with 8 weeks prior to baseline. Subjects who has chronic dermatological conditions (eczema, psoriasis, etc) of the scalp other than male pattern baldness</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>HairMax LaserComb 2009, 12 Beam</title>
          <description>LLLT Device 2009 12 Beam, Control Device</description>
        </group>
        <group group_id="P2">
          <title>HairMax LaserComb 2009 9 Beam</title>
          <description>LLLT Device 2009 9 Beam, Control Device</description>
        </group>
        <group group_id="P3">
          <title>Control Device</title>
          <description>Control device emitting LED light</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="28"/>
                <participants group_id="P2" count="25"/>
                <participants group_id="P3" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="21"/>
                <participants group_id="P3" count="22"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>HairMax LaserComb 2009, 12 Beam</title>
          <description>LLLT Device 2009 12 Beam, Control Device</description>
        </group>
        <group group_id="B2">
          <title>HairMax LaserComb 2009 9 Beam</title>
          <description>LLLT Device 2009 9 Beam, Control Device</description>
        </group>
        <group group_id="B3">
          <title>Control Device</title>
          <description>Control device emitting LED light</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="28"/>
            <count group_id="B2" value="25"/>
            <count group_id="B3" value="26"/>
            <count group_id="B4" value="79"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="26"/>
                    <measurement group_id="B4" value="79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="26"/>
                    <measurement group_id="B4" value="79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Changes in Terminal Hair Count at 16 and 26 Weeks Compared to Baseline in Men Diagnosed With Androgenetic Alopecia</title>
        <description>The primary analysis of effectiveness was an analysis of covariance, which separately modeled terminal hair count at Week 16 and Week 26 as a function of treatment group (HairMax LaserComb 2009 9 Beam vs.control), study center, age (as a continuous variable), and Fitzpatrick Skin Type classification (as a categorical variable with four levels). The active group was compared to the control device using least squares means with a two-sided test at the 5% level of significance.</description>
        <time_frame>baseline, 16 and 26 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>HairMax LaserComb 2009, 12 Beam</title>
            <description>The active LLLT Device 2009 with 12 laser modules</description>
          </group>
          <group group_id="O2">
            <title>HairMax LaserComb 2009 9 Beam</title>
            <description>the active LLLT Device 2009 9 laser modules</description>
          </group>
          <group group_id="O3">
            <title>Control Device</title>
            <description>Control device emitting white light</description>
          </group>
        </group_list>
        <measure>
          <title>Changes in Terminal Hair Count at 16 and 26 Weeks Compared to Baseline in Men Diagnosed With Androgenetic Alopecia</title>
          <description>The primary analysis of effectiveness was an analysis of covariance, which separately modeled terminal hair count at Week 16 and Week 26 as a function of treatment group (HairMax LaserComb 2009 9 Beam vs.control), study center, age (as a continuous variable), and Fitzpatrick Skin Type classification (as a categorical variable with four levels). The active group was compared to the control device using least squares means with a two-sided test at the 5% level of significance.</description>
          <units>hairs per cm^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="21"/>
                <count group_id="O3" value="22"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>hairs per cm^2</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="21"/>
                <count group_id="O3" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Change at 16 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.5" spread="17.67"/>
                    <measurement group_id="O2" value="20.4" spread="14.52"/>
                    <measurement group_id="O3" value="4.4" spread="8.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at 26 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.7" spread="16.92"/>
                    <measurement group_id="O2" value="20.9" spread="14.08"/>
                    <measurement group_id="O3" value="9.4" spread="12.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>HairMax LaserComb 2009, 12 Beam</title>
          <description>LLLT Device 2009 12 Beam, Control Device</description>
        </group>
        <group group_id="E2">
          <title>HairMax LaserComb 2009 9 Beam</title>
          <description>LLLT Device 2009 9 Beam, Control Device</description>
        </group>
        <group group_id="E3">
          <title>Control Device</title>
          <description>Control device emitting LED light</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>4</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>David Michaels</name_or_title>
      <organization>Lexington International, LLC</organization>
      <phone>561-417-0200</phone>
      <email>dm@hairmax.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

